產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Gene sequencing
SDS-PAGE圖
通過ISO 9001、ISO 13485質(zhì)量體系認證
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務
相關產(chǎn)品
| 編號 | 適用物種：Rattus norvegicus (Rat，大鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPB275Ra01 | 膜輔蛋白(MCP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB275Ra01 | 膜輔蛋白(MCP)多克隆抗體 | WB; IHC; ICC; IP. |
| LAB275Ra81 | 膜輔蛋白(MCP)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| LAB275Ra71 | 膜輔蛋白(MCP)多克隆抗體(生物素標記) | WB; IHC; ICC. |
參考文獻
| 雜志 | 參考文獻 |
| Cardiovascular?Diabetology | Cyclophilin?A?enhances?macrophage?differentiation?and?lipid?uptake?in?high?glucose?conditions: a cellular mechanism for accelerated macro vascular disease in diabetes mellitus.[pubmed:27809851] |
| Biomedical?Reports | Pre-treatment with simvastatin prevents the induction of diet-induced atherosclerosis in a rabbit model[pubmed:28101339] |
| Thrombosis?Research | Alternative pathway activation due to low level of complement factor H in primary antiphospholipid syndrome[Pubmed:29494857] |